The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...

Tandem Diabetes Care shows improving revenue and margins, but faces ongoing losses, high expenses, and stiff competition from ...

A phase 1 trial, LUMINA, is currently underway and is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of AMX0114 in approximately 48 patients with ALS.

The bolus is delivered using the bolus dose feature with a smart infusion pump that allows programming of both the bolus dose and continuous infusion rate, and then automatically switches to the ...

In an attempt to stop the preterm labor from progressing, the obstetrician prescribed IV magnesium sulfate, with a bolus dose of 6 g over 30 minutes followed by a continuous infusion of 2 g/hour.

Findings from the Chinese randomized trial support what most centers in the US are already doing, one expert says.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. Our lead indication for 4D-150 is wet age-related macular degeneration, which is ...

One infusion was poorly absorbed, but SSCIs were otherwise well tolerated. Conclusions SSCIs appear to be a promising additional option for administering medicines that are too irritant or large in ...

15 Administration of intravenous bolus or intravenous infusion ≥15% faster than recommended. Wrong mixture: use of a solvent/diluent/additive that was incorrect according to the Australian Injectable ...

At Aidex CGM, we are committed to improving the lives of individuals with diabetes by providing innovative, reliable, and ...